Breaking News

PPD Adds Central Lab Ops to Clinical Data Platform

February 10, 2016

Aims to enhance efficiency of managing central lab data

PPD is expanding Preclarus clinical data platform to include data solutions that support the company’s central lab operations. This will enable study sites to access central lab data in real time, as well as inventory management and order tracking, facilitate patient management and safety, and establish complete chain of custody for samples.   
The new Preclarus investigator site portal consolidates and standardizes data from multiple sources providing real-time access to clinical trial operations and patient data, which can be visualized on interactive dashboards, as well as analytics to support innovative research approaches.
The new central lab portal is designed to make it easier for investigational sites to support PPD clinical trials. The reports and tools include adding patients to the trial, ordering sample collection kits, reviewing lab results, managing patients and critical values, and shipping samples to PPD. The new portal also provides on-site biorepository tools to help clients manage samples at their site and track them.
“Preclarus offers our clients an unprecedented view of central laboratory data that support their clinical trials,” explains David Johnston, Ph.D., executive vice president of PPD Laboratories. “With its real-time access to study details, patient data and laboratory results, Preclarus drives informed decision-making and increased efficiency for PPD Laboratories and its clients.”
  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials